Aalborg University Hospital
Aalborg University Hospital is recorded as a service provider in 16 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 16 of 16 trials · Latest update first
A Randomized, placebo-controlled, double-blinded Phase 2 Trial of Dapagliflozin for Preventing Treatment-associated Cardiotoxicity in Lymphoma
Sponsor Aalborg University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (15 cycles) venetoclax/ pirtobrutinib vs. MRD-guided venetoclax/ pirtobrutinib in patients with previously untreated chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL) aiming to establish measurement of individual residual disease for adjustment of treatment duration to improve outcomes (CLL18/MOIRAI)
Sponsor University Of Cologne
- Start (EU)
- Latest update
- Estimated end
Lithium versus cariprazine in the acute phase treatment of bipolar depression: a pragmatic head-to-head open, randomized multicenter study. The 9th study of the Danish University Antidepressant Group (DUAG 9).
Sponsor Aalborg University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Effect of tirzepatide on alcohol intake and reward processing in patients diagnosed with schizophrenia and alcohol use disorder
Sponsor Region Hovedstaden
- Start (EU)
- Latest update
- Estimated end
- Not reported
Nordic PREdnisolon for VEstibular NeuriTis Study – an investigator-driven, triple blind, placebo controlled randomized trial
Sponsor Region Vaesterbotten
- Start (EU)
- Latest update
- Estimated end
- Not reported
Efficacy and safety of cannabidiol for pain relief of patients with end-stage metastatic castration resistant prostate cancer - a randomised double-blinded placebo-controlled phase II trial (ProCan)
Sponsor Regionshospital Nordjylland
- Start (EU)
- Latest update
- Estimated end
- Not reported
A randomized phase II study of gemcitabine versus reduced-dose combination chemotherapy in fragile patients with non-resectable pancreatic cancer
Sponsor Aalborg University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
DANOHCA: The Danish Out-of-Hospital Cardiac Arrest study
Sponsor Rigshospitalet
- Start (EU)
- Latest update
- Estimated end
- Not reported
Tocilizumab for Painful Chronic Pancreatitis: A Randomised, Placebo-controlled, Double-blinded, Investigator-initiated Trial (TOPAC trial)
Sponsor Aalborg University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Optimising Arthritis Strategies in Elderly patients (≥70 years) with rheumatoid arthritis in sustained low disease activity (the OASE study): A Prospective Target Trial Emulation Study Evaluating Tapering of Disease-Modifying Anti-Rheumatic Drugs vs. Usual Care Based on Patient Preference
Sponsor Aalborg University Hospital
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
PERCUTANEOUS EMBOLECTOMY, LOW DOSE THROMBOLYSIS OR HEPARIN FOR INTERMEDIATE HIGH RISK PULMONARY EMBOLISM
Sponsor Rigshospitalet
- Start (EU)
- Latest update
- Estimated end
- Not reported
Pharmacokinetics and pharmacodynamics of intravenous versus enteral amiodarone in critically ill patients with new-onset atrial fibrillation – a randomised controlled pilot trial
Sponsor Aalborg University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
FAPI PET in Pleural Mesothelioma: The Diagnostic Accuracy and Clinical Value of FAPI PET at Diagnosis, Primary Staging, and the Feasibility of FAPI PET for Response Evaluation
Sponsor Aalborg University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Danish non-inferiority study of ocrelizumab and rituximab in MS: A randomized study comparing the efficacy of ocrelizumab and rituximab in active multiple sclerosis
Sponsor Rigshospitalet
- Start (EU)
- Latest update
- Estimated end
- Not reported
Pomalidomide in people with chronic hepatitis B virus (HBV) infection: Safety and immune-enhancing effects (The PIPPI Study)
Sponsor Region Midtjylland
- Start (EU)
- Latest update
- Estimated end
- Not reported
Aciclovir for HSV-2 MENingitis: A double-blinded randomised controlled trial (AMEN)
Sponsor Aalborg University Hospital
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Aalborg University Hospital?
The 2026-10-09 snapshot links Aalborg University Hospital to 16 distinct CTIS trials. Recorded services include Clinical monitoring, Investigator recruitment, Laboratory services, Safety reporting & pharmacovigilance. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Aalborg University Hospital?
The most frequently recorded therapeutic areas are Haematological Malignancies, Cardiology, Neurology, Other. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Aalborg University Hospital conducted?
The linked trials record locations in 14 countries, including Denmark, Norway, Sweden, Austria, Belgium. These are trial locations, not confirmed office locations or countries where Aalborg University Hospital delivered services.
What can this page tell me about Aalborg University Hospital's trial experience?
Browse 16 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Aalborg University Hospital. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Aalborg University Hospital